Volume 31, Issue 4 (July 2020)
Studies in Medical Sciences 2020, 31(4): 316-324 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Panahi Y, Monnazah M A, Vafaei G. STUDY OF THE USE OF DIMETHYL SULFOXIDE (DMSO) AS A SOLVENT IN THE ADMINISTRATION OF ANTIEPILEPTIC DRUGS. Studies in Medical Sciences 2020; 31 (4) :316-324
URL: http://umj.umsu.ac.ir/article-1-5083-en.html
URL: http://umj.umsu.ac.ir/article-1-5083-en.html
Division of Pharmacology and Toxicology, Department of Basic science, Faculty of Veterinary Medicine, University of Tabriz, Tabriz, Iran (Corresponding Author) , y.panahi@
Abstract: (11287 Views)
Background & Aims: DMSO is a compound that is widely used to dissolve and deliver many water-insoluble compounds and has various biological effects on the central nervous system. So the aim of this study was to investigate the effects of dimethyl sulfoxide on experimental epileptic-like activities induced by intraperitoneal injection of pentylenetetrazole in adult male rats.
Materials & Methods: In this study, 20 adult male Wistar rats (200-250 g) were used in 4 groups. The control group (5 heads) received normal saline (200 µl) and the 3 groups (15 heads, 5 heads per subgroup) were treated with 10, 50 and 100% DMSO (200µl) intraperitoneally, respectively. After anesthesia with the combination of ketamine-xylazine (80+8 mg/kg) and surgery of the animal skull, the electrode was inserted into the skull layer in the CA1 hippocampal striatum layer and epileptic activities were induced by intraperitoneal injection of pentylenetetrazol (80 mg/kg) and epileptic activity was measured and evaluated in terms of number of spikes per unit time and their amplitude by eTrace software.
Results: The results of the present study showed that injectable dimethyl sulfoxide has a dose-dependent effect on pentylenetetrazol-induced epileptiform activity in the hippocampus, so that the concentration of 10% reduced the desired activity significantly (p<0.05) compared to the control group. So, it has protective effect against pentylenetetrazol-induced epileptiform activity. While concentration of 100% dimethylsulfoxide significantly (p<0.05) increased pentylenetetrazol-induced epileptiform activity compared tocontrol group and had proconvulsant effect in seizure activity. However, 50% concentration of dimethyl sulfoxide had no significant effect on the activity.
Conclusion: Low concentrations of dimethylsulfoxide are likely to be used as novel drug solvents for different models of epilepsy to deliver the drug to the central nervous system, however further investigation and testing are needed.
Materials & Methods: In this study, 20 adult male Wistar rats (200-250 g) were used in 4 groups. The control group (5 heads) received normal saline (200 µl) and the 3 groups (15 heads, 5 heads per subgroup) were treated with 10, 50 and 100% DMSO (200µl) intraperitoneally, respectively. After anesthesia with the combination of ketamine-xylazine (80+8 mg/kg) and surgery of the animal skull, the electrode was inserted into the skull layer in the CA1 hippocampal striatum layer and epileptic activities were induced by intraperitoneal injection of pentylenetetrazol (80 mg/kg) and epileptic activity was measured and evaluated in terms of number of spikes per unit time and their amplitude by eTrace software.
Results: The results of the present study showed that injectable dimethyl sulfoxide has a dose-dependent effect on pentylenetetrazol-induced epileptiform activity in the hippocampus, so that the concentration of 10% reduced the desired activity significantly (p<0.05) compared to the control group. So, it has protective effect against pentylenetetrazol-induced epileptiform activity. While concentration of 100% dimethylsulfoxide significantly (p<0.05) increased pentylenetetrazol-induced epileptiform activity compared tocontrol group and had proconvulsant effect in seizure activity. However, 50% concentration of dimethyl sulfoxide had no significant effect on the activity.
Conclusion: Low concentrations of dimethylsulfoxide are likely to be used as novel drug solvents for different models of epilepsy to deliver the drug to the central nervous system, however further investigation and testing are needed.
Type of Study: Research |
Subject:
Neuroscience
References
1. Allen NJ, Barres BA. Glia-more than just brain glue. Nature 2009; 457(7230):675-7. [DOI:10.1038/457675a] [PMID]
2. Ballough GP, Kan RK, Nicholson JD, Fath DM, Tompkins CP, Moffa GM, et al. Brain damage from soman-induced seizures is greatly exacerbated by dimethyl sulfoxide (DMSO): Modest neuroprotection by 2-aminoethyl diphenylborinate (2-APB), a transient receptor potential channel inhibitor and inositol 1, 4, 5-triphosphate receptor antagonist. ARMY MEDICAL RESEARCH INST OF CHEMICAL DEFENSE ABERDEEN PROVING GROUND MD; 2008.
3. Bardutzky J, Meng X, Bouley J, Duong TQ, Ratan R, Fisher M. Effects of intravenous dimethyl sulfoxide on ischemia evolution in a rat permanentocclusion model. J Cereb Blood Flow Metab 2005; 25(8):968-77. [DOI:10.1038/sj.jcbfm.9600095] [PMID] [PMCID]
4. Bauwens D, Hantson P, Laterre P-F, Michaux L, Latinne D, De Tourtchaninoff M, et al. Recurrent seizure and sustained encephalopathy associated with dimethylsulfoxide-preserved stem cell infusion. Leuk Lymphoma 2005; 46(11):1671-4. [DOI:10.1080/10428190500235611] [PMID]
5. Blair RE, Deshpande LS, Sombati S, Falenski KW, Martin BR, DeLorenzo RJ. Activation of the cannabinoid type-1 receptor mediates the anticonvulsant properties of cannabinoids in the hippocampal neuronal culture models of acquired epilepsy and status epilepticus. J Pharmacol Exp Ther 2006; 317(3):1072-8. [DOI:10.1124/jpet.105.100354] [PMID]
6. Brown FD, Johns LM, Mullan S. Dimethyl sulfoxide in experimental brain injury, with comparison to mannitol. J Neurosurg 1980; 53(1):58-62.DMSO [DOI:10.3171/jns.1980.53.1.0058] [PMID]
7. Camp P, James H, Werner R. Acute Dimethyl Sulfoxide Therapy in Experimental Brain Edema: Part 1: Effects on Intracranial Pressure, Blood Pressure, Central Venous Pressure, and Brain Water and Electrolyte Content. Neurosurgery 1981; 9(1):28-33.
https://doi.org/10.1097/00006123-198107000-00005 [DOI:10.1227/00006123-198107000-00005] [PMID]
8. Carletti F, Ferraro G, Rizzo V, Cannizzaro C, Sardo P. Antiepileptic effect of dimethyl sulfoxide in a rat model of temporal lobe epilepsy. Neurosci Lett 2013; 546:31-5. [DOI:10.1016/j.neulet.2013.04.031] [PMID]
9. Del Bigio M, James H, Camp PE, Werner R, Marshall LF, Tung H. Acute Dimethyl Sulfoxide Therapy in Brain Edema: Part 3: Effect of a 3-Hour Infusion. Neurosurgery 1982; 10(1):86-9.
https://doi.org/10.1227/00006123-198201000-00014 [DOI:10.1097/00006123-198201000-00014] [PMID]
10. Deshpande LS, Blair RE, Ziobro JM, Sombati S, Martin BR, DeLorenzo RJ. Endocannabinoids block status epilepticus in cultured hippocampal neurons. Eur J Pharmacol 2007; 558(1-3):52-9. [DOI:10.1016/j.ejphar.2006.11.030] [PMID] [PMCID]
11. Deshpande LS, Sombati S, Blair RE, Carter DS, Martin BR, DeLorenzo RJ. Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsy. Neurosci Lett 2007; 411(1):11-6. [DOI:10.1016/j.neulet.2006.09.046] [PMID] [PMCID]
12. Evans R, Smith D. Effect of urethane on synaptic and amino acid-induced excitation in isolated spinal cord preparations. Neuropharmacology 1982; 21(9):857-60. [DOI:10.1016/0028-3908(82)90076-4] [PMID]
13. Felder CC, Joyce KE, Briley EM, Mansouri J, Mackie K, Blond O, et al. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol Pharmacol 1995; 48(3):443-50. [Google Scholar]
14. Gebel T, Koenig A. Impact of dimethyl sulfoxide and examples of combined genotoxicity in the SOS chromotest. Mutat Res Genet Toxicol Environ Mutagen 1999; 444(2):405-11. [DOI:10.1016/S1383-5718(99)00111-4] [PMID]
15. Gurtovenko AA, Anwar J. Modulating the structure and properties of cell membranes: the molecularmechanism of action of dimethyl sulfoxide. J Phys Chem B 2007; 111(35):10453-60. [DOI:10.1021/jp073113e] [PMID]
16. Jacob SW, Jack C. Pharmacology of dimethyl sulfoxide in cardiac and CNS damage. Pharmacol Rep 2009; 61(2):225-35. [DOI:10.1016/S1734-1140(09)70026-X] [PMID]
17. Kovács Z, Czurkó A, Kékesi KA, Juhász G. The effect of intraperitoneally administered dimethyl sulfoxide on absence-like epileptic activity of freely moving WAG/Rij rats. J Neurosci Methods 2011; 197(1):133-6. [DOI:10.1016/j.jneumeth.2011.02.005] [PMID]
18. Larsen J, Gasser K, Hahin R. An analysis of dimethylsulfoxide-induced action potential block: a comparative study of DMSO and other aliphatic water soluble solutes. Toxicol Appl Pharmacol 1996; 140(2):296-314. [DOI:10.1006/taap.1996.0225] [PMID]
19. Lu C, Mattson MP. Dimethyl sulfoxide suppresses NMDA-and AMPA-induced ion currents and calcium influx and protects against excitotoxic death in hippocampal neurons. Exp Neurol 2001; 170(1):180-5. [DOI:10.1006/exnr.2001.7686] [PMID]
20. Maral S, Albayrak M, Pala C, Yildiz A, Sahin O, Ozturk HB. Dimethyl sulfoxide-induced tonic-clonic seizure and cardiac arrest during infusion of autologous peripheral blood stem cells. Cell Tissue Bank 2018; 19(4):831-2. [DOI:10.1007/s10561-018-9718-x] [PMID]
21. Marcacci G, Corazzelli G, Becchimanzi C, Arcamone M, Capobianco G, Russo F, et al. DMSO-associated encephalopathy during autologous peripheral stem cell infusion: a predisposing role of preconditioning exposure to CNS-penetrating agents? Bone Marrow Transplant 2009; 44(2):133-5. [DOI:10.1038/bmt.2008.442] [PMID]
22. Nakahiro M, Arakawa O, Narahashi T, Ukai S, Kato Y, Nishinuma K, et al. Dimethyl sulfoxide (DMSO) blocks GABA-induced current in rat dorsal root ganglion neurons. Neurosci Lett 1992; 138(1):5-8. [DOI:10.1016/0304-3940(92)90459-K] [PMID]
23. Nasrallah FA, Garner B, Ball GE, Rae C. Modulation of brain metabolism by very low concentrations of the commonly used drug deliveryvehicle dimethyl sulfoxide (DMSO). J Neurosci Res 2008; 86(1):208-14. [DOI:10.1002/jnr.21477] [PMID]
24. Noel PR, Barnett KC, Davies RE, Jolly DW, Leahy JS, Mawdesley-Thomas LE, et al. The toxicity of dimethyl sulphoxide (DMSO) for the dog, pig, rat and rabbit. Toxicology 1975; 3(2):143-69. [DOI:10.1016/0300-483X(75)90081-5] [PMID]
25. Parkinson D. Treatment of head injury in mice, using a fructose 1, 6-diphosphate and dimethyl sulfoxide combination. Neurosurgery 1996; 38(1):232. [DOI:10.1097/00006123-199601000-00067] [PMID]
26. Rizzo V, Ferraro G, Carletti F, Lonobile G, Cannizzaro C, Sardo P. Evidences of cannabinoids-induced modulation of paroxysmal events in an experimental model of partial epilepsy in the rat. Neurosci Lett. 2009; 462(2):135-9. [DOI:10.1016/j.neulet.2009.07.014] [PMID]
27. Santos NC, Figueira-Coelho J, Martins-Silva J, Saldanha C. Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects. Biochem Pharmacol 2003; 65(7):1035-41. [DOI:10.1016/S0006-2952(03)00002-9] [PMID]
28. Sardo P, Carletti F, D'Agostino S, Rizzo V, Ferraro G. Involvement of nitric oxide-soluble guanylyl cyclase pathway in the control of maximal dentate gyrus activation in the rat. J Neural Transm 2006; 113(12):1855-61. [DOI:10.1007/s00702-006-0491-9] [PMID]
29. Tarasenko A, Linetska M, Storchak L, Himmelreich N. Effectiveness of extracellular lactate/pyruvate for sustaining synaptic vesicle proton gradient generation and vesicular accumulation of GABA. J Neurochem 2006; 99(3):787-96. [DOI:10.1111/j.1471-4159.2006.04109.x] [PMID]
30. Torre Jdl. Synergic activity of combined prostacyclin: dimethyl sulfoxide in experimental brain ischemia. Can J Physiol Pharmacol 1991; 69(2):191-8. [DOI:10.1139/y91-028] [PMID]
31. Tsvyetlynska NA, Hill RH, Grillner S. Role of AMPA receptor desensitization and the side effects of a DMSO vehicle on reticulospinal EPSPs and locomotor activity. J Neurophysiol 2005; 94(6):3951-60. [DOI:10.1152/jn.00201.2005] [PMID]
32. Van Pelt L. Ketamine and xylazine for surgical anesthesia in rats. J Am Vet Med Assoc 1977; 171(9):842-4. [PMID]
33. Wang H-Y, Ma L, Li Y, Cho C-H. Exposure to cigarette smoke increases apoptosis in the rat gastric mucosa through a reactive oxygen species-mediated and p53-independent pathway. Free Radic Biol Med 2000; 28(7):1125-31. [DOI:10.1016/S0891-5849(00)00207-0] [PMID]
34. Wu Q, Wang H. The spatiotemporal expression changes of CB2R in the hippocampus of rats following pilocarpine-induced status epilepticus. Epilepsy Res 2018; 148:8-16. [DOI:10.1016/j.eplepsyres.2018.10.002] [PMID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
